Pharvaris (PHVS) EBIT Growth (1y) (2021 - 2026)
Pharvaris (PHVS) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 183.45% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | 100.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | 34,709,733,639,158.36% |
| Sep 30, 2025 | 100.00% |
| Jun 30, 2025 | -60.46% |
| Mar 31, 2025 | -144,276,873,010,187.53% |
| Dec 31, 2024 | 99.94% |
| Sep 30, 2024 | -63.04% |
| Jun 30, 2024 | -34.53% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | -332,972.95% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | -4.06% |
| Mar 31, 2023 | -104,006,477.40% |
| Dec 31, 2022 | -58.16% |
| Sep 30, 2022 | -143,585,227.31% |
| Jun 30, 2022 | -48.88% |
| Mar 31, 2022 | -52.25% |
| Dec 31, 2021 | -278.17% |
| Sep 30, 2021 | -114.52% |
| Jun 30, 2021 | -142.99% |